Laminin-521: a novel target for pathogenic autoantibodies in anti-glomerular basement membrane disease. Robson KJ. Kidney Int 2023;104:1054-1056.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Robson KJ. Laminin-521: a novel target for pathogenic autoantibodies in anti-glomerular basement membrane disease. Kidney Int 2023;104:1054-1056.
PMID: 37981425